INTERPACE BIOSCIENCES, INC. Deferred State and Local Income Tax Expense (Benefit)
INTERPACE BIOSCIENCES, INC. (IDXGD) reported Deferred State and Local Income Tax Expense (Benefit) of -$3.47 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-03-30
- INTERPACE BIOSCIENCES, INC. deferred state and local income tax expense (benefit) for fiscal 2025 was -$3.47M.
- INTERPACE BIOSCIENCES, INC. deferred state and local income tax expense (benefit) for fiscal 2021 was $14.00K, a 0.00% change from fiscal 2020.
- INTERPACE BIOSCIENCES, INC. deferred state and local income tax expense (benefit) for fiscal 2020 was $14.00K, a 100.00% increase from fiscal 2019.
- INTERPACE BIOSCIENCES, INC. deferred state and local income tax expense (benefit) for fiscal 2019 was $7.00K.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$3.47M 10-K · filed 2026-03-30 |
| 2021-12-31 | $14.00K 10-K · filed 2022-03-31 |
| 2020-12-31 | $14.00K 10-K · filed 2022-03-31 |
| 2019-12-31 | $7.00K 10-K · filed 2021-04-01 |
| 2015-12-31 | -$1.17M 10-K · filed 2017-03-31 |
| 2014-12-31 | -$349.00K 10-K · filed 2016-03-30 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-05 |
| 2012-12-31 | -$9.00K 10-K · filed 2014-03-06 |
| 2011-12-31 | -$4.00K 10-K · filed 2013-03-15 |